233 related articles for article (PubMed ID: 9733833)
21. Gag-Gag interactions in the C-terminal domain of human immunodeficiency virus type 1 p24 capsid antigen are essential for Gag particle assembly.
Zhang WH; Hockley DJ; Nermut MV; Morikawa Y; Jones IM
J Gen Virol; 1996 Apr; 77 ( Pt 4)():743-51. PubMed ID: 8627263
[TBL] [Abstract][Full Text] [Related]
22. Particle size determinants in the human immunodeficiency virus type 1 Gag protein.
Garnier L; Ratner L; Rovinski B; Cao SX; Wills JW
J Virol; 1998 Jun; 72(6):4667-77. PubMed ID: 9573230
[TBL] [Abstract][Full Text] [Related]
23. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly.
Spearman P; Wang JJ; Vander Heyden N; Ratner L
J Virol; 1994 May; 68(5):3232-42. PubMed ID: 8151785
[TBL] [Abstract][Full Text] [Related]
24. The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner.
Demirov DG; Orenstein JM; Freed EO
J Virol; 2002 Jan; 76(1):105-17. PubMed ID: 11739676
[TBL] [Abstract][Full Text] [Related]
25. RNA incorporation is critical for retroviral particle integrity after cell membrane assembly of Gag complexes.
Wang SW; Aldovini A
J Virol; 2002 Dec; 76(23):11853-65. PubMed ID: 12414928
[TBL] [Abstract][Full Text] [Related]
26. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity.
Reicin AS; Paik S; Berkowitz RD; Luban J; Lowy I; Goff SP
J Virol; 1995 Feb; 69(2):642-50. PubMed ID: 7815527
[TBL] [Abstract][Full Text] [Related]
27. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.
Kondo E; Mammano F; Cohen EA; Göttlinger HG
J Virol; 1995 May; 69(5):2759-64. PubMed ID: 7707498
[TBL] [Abstract][Full Text] [Related]
28. Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag).
Sandefur S; Smith RM; Varthakavi V; Spearman P
J Virol; 2000 Aug; 74(16):7238-49. PubMed ID: 10906178
[TBL] [Abstract][Full Text] [Related]
29. trans-acting proteins involved in RNA encapsidation and viral assembly in human immunodeficiency virus type 1.
Kaye JF; Lever AM
J Virol; 1996 Feb; 70(2):880-6. PubMed ID: 8551627
[TBL] [Abstract][Full Text] [Related]
30. The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle.
Reicin AS; Ohagen A; Yin L; Hoglund S; Goff SP
J Virol; 1996 Dec; 70(12):8645-52. PubMed ID: 8970990
[TBL] [Abstract][Full Text] [Related]
31. Lipid biosensor interactions with wild type and matrix deletion HIV-1 Gag proteins.
Barklis E; Staubus AO; Mack A; Harper L; Barklis RL; Alfadhli A
Virology; 2018 May; 518():264-271. PubMed ID: 29549788
[TBL] [Abstract][Full Text] [Related]
32. Human immunodeficiency virus type 1 virion density is not determined by nucleocapsid basic residues.
Cimarelli A; Luban J
J Virol; 2000 Aug; 74(15):6734-40. PubMed ID: 10888611
[TBL] [Abstract][Full Text] [Related]
33. Mutational analysis of the C-terminal gag cleavage sites in human immunodeficiency virus type 1.
Coren LV; Thomas JA; Chertova E; Sowder RC; Gagliardi TD; Gorelick RJ; Ott DE
J Virol; 2007 Sep; 81(18):10047-54. PubMed ID: 17634233
[TBL] [Abstract][Full Text] [Related]
34. Bovine leukemia virus Gag particle assembly in insect cells: formation of chimeric particles by domain-switched leukemia/lentivirus Gag polyprotein.
Kakker NK; Mikhailov MV; Nermut MV; Burny A; Roy P
Virology; 1999 Dec; 265(2):308-18. PubMed ID: 10600602
[TBL] [Abstract][Full Text] [Related]
35. Effects of gag mutations on human immunodeficiency virus type 1 particle assembly, processing, and cyclophilin A incorporation.
Chiu HC; Wang FD; Yao SY; Wang CT
J Med Virol; 2002 Oct; 68(2):156-63. PubMed ID: 12210402
[TBL] [Abstract][Full Text] [Related]
36. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.
Sova P; Volsky DJ; Wang L; Chao W
J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958
[TBL] [Abstract][Full Text] [Related]
37. Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins.
Huvent I; Hong SS; Fournier C; Gay B; Tournier J; Carrière C; Courcoul M; Vigne R; Spire B; Boulanger P
J Gen Virol; 1998 May; 79 ( Pt 5)():1069-81. PubMed ID: 9603321
[TBL] [Abstract][Full Text] [Related]
38. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
39. Proline residues in human immunodeficiency virus type 1 p6(Gag) exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins.
Dettenhofer M; Yu XF
J Virol; 1999 Jun; 73(6):4696-704. PubMed ID: 10233929
[TBL] [Abstract][Full Text] [Related]
40. The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly.
Borsetti A; Ohagen A; Göttlinger HG
J Virol; 1998 Nov; 72(11):9313-7. PubMed ID: 9765481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
